" â€™    Gottlieb emerged early on as a favorite among members of the drug   industry. Salim Syed, a biotech analyst at Mizuho, asked   pharma executives who they would like to see as the next FDA   commissioner. The overwhelming majority (72%) said   Gottlieb.   